Institutional investors hold a majority ownership of CELG through the 83.86% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2014, these large investors purchased a net $6.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ETHENEA INDEPENDENT INVESTORS SA Bought 638.0 Thousand shares of Celgene
ATALANTA SOSNOFF MANAGEMENT LLC Bought 143.8 Thousand shares of Celgene
VIRGINIA RETIREMENT SYSTEMS Bought 68.7 Thousand shares of Celgene